Contract for the Supply of rotavirus vaccine
Department of Health and Social Care (DHSC)contractContracts Finder ↗Ref CF-0027900D0O000000rwimUAA4complete
Estimated value
—
Awarded value
£224.0m
Awarded 17 Sept 2020
Suppliers
1
Lots
1
1 awarded
Published
01 Dec 2020
Deadline 14 May 2020
Other contracts from Department of Health and Social Care (DHSC)· 10
Most recent notices published by the same contracting authority.
| Title | Type | Value | Published |
|---|---|---|---|
| DHSC: MedTech - Compass Alpha | contract | £575k | 21 Nov 2025 |
| DHSC: CL: PPE Dissolution Team SP | contract | £87k | 02 Sept 2025 |
| DHSC Workforce Solutions | contract | £18.0m | 16 Jun 2025 |
| DHSC: FGO: Contingent Labour SB | contract | £49k | 16 Jun 2025 |
| DHSC:FGO Health PFI advice | contract | £30k | 04 Jun 2025 |
| DHSC:FGO: Training Needs Analysis (TNA) | contract | £150k | 02 Jun 2025 |
| DHSC:OHID:Water Fluoridation Engineering Support | contract | £1.1m | 21 May 2025 |
| DHSC: Group Finance: Finance Information Consolidation System | contract | £617k | 24 Apr 2025 |
| DHSC: FGO Employee Benefits Reward & Recognition scheme FY24-25 | contract | — | 15 Apr 2025 |
| DHSC: SFG measures TSO and Business training | contract | £115k | 11 Apr 2025 |
Other contracts awarded to GlaxoSmithKline UK Limited· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| Meningitis B Vaccine (2026) | contract | — | 22 May 2026 |
| Herpes zoster, inactivated vaccine (2027) | contract | — | 13 Mar 2026 |
| NHS National Generic Pharmaceuticals - Wave 15c | contract | — | 26 Feb 2026 |
| NHS National Generic Pharmaceuticals - Wave 15c | contract | — | 14 Jan 2026 |
| Meningitis B vaccine (2026) | contract | — | 09 Sept 2025 |
| Measles, Mumps, Rubella and Varicella (MMRV) vaccine (2025) | contract | — | 29 Aug 2025 |
| NHS National Generic Pharmaceuticals Wave 15b | contract | — | 04 Aug 2025 |
| NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 | contract | £47.0m | 29 Jul 2025 |
| NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025 | contract | — | 29 Jul 2025 |
| NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National | contract | £9.4m | 24 Jul 2025 |